Melanocortin Receptor
Inhibitory Selectivity
Melanocortin Receptor Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| P1108New |
Bremelanotide AcetateBremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty. |
||
| S0019 |
JNJ-10229570JNJ-10229570 (UNII-N9IX402L35) is a potent MC1R and MC5R antagonist. |
||
| E1002New |
Setmelanotide (RM-493)Setmelanotide (RM-493, BIM-22493, CAM 4072) is a cyclic peptide full agonist of melanocortin-4 receptor (MC4R) with an EC50 of 0.27 nM and a Ki of 2.1 nM. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| P1108New |
Bremelanotide AcetateBremelanotide Acetate (PT-141 Acetate) is a melanocortin receptor (MCR) agonist recently approved in the USA for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S0019 |
JNJ-10229570JNJ-10229570 (UNII-N9IX402L35) is a potent MC1R and MC5R antagonist. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| E1002New |
Setmelanotide (RM-493)Setmelanotide (RM-493, BIM-22493, CAM 4072) is a cyclic peptide full agonist of melanocortin-4 receptor (MC4R) with an EC50 of 0.27 nM and a Ki of 2.1 nM. |
